Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 11/14/08  and contains information from public web pages.

Dr. Luca Vangelista

Wrong Dr. Luca Vangelista?
 
Background

Employment History

12 Total References
Web References
AllergoOncology Portal - Luca Vangelista
www.allergooncology.org [cached]
Luca Vangelista AllergoOncology Portal - Luca Vangelista
...
Luca Vangelista
...
Dr. Luca Vangelista San Raffaele Scientific Institute
...
Dr. Luca Vangelista spent over a decade in several European laboratories, in the commitment to characterize molecular and structural biology aspects of IgE, FceRI and recombinant allergens. In 2003 he moved to Milan where he joined Prof. Antonio Siccardi as an independent Scientist at the San Raffaele Scientific Institute and the Department of Biology and Genetics of the University of Milan. He is developing innovative strategies to combat tumors using exogenous IgE and its derivatives and is investigating the role of endogenous IgE in tumor surveillance.
Microbicides 2008: Third-generation microbicides might act as ‘bacterial vaccine’ — Microbicides Media and Communications Initiative
www.mmci-communications.org [cached]
Finally, in experiments combining both approaches, Luca Vangelista of the San Raffaele Scientific Institute in Italy has engineered the same lactobacilli as in the Xu study to produce human-type RANTES and is currently engineering another variant that will produce an analogue called C1C5-RANTES, and also small peptides - sections - derived from RANTES to see if these have anti-HIV activity.
BCPWA HIV/AIDS eNews - March 14, 2008
bcpwa.baremetal.com [cached]
Finally, in experiments combining both approaches, Luca Vangelista of the San Raffaele Scientific Institute in Italy has engineered the same lactobacilli as in the Xu study to produce human-type RANTES and is currently engineering another variant that will produce an analogue called C1C5-RANTES, and also small peptides , sections , derived from RANTES to see if these have anti-HIV activity.
Finally, in experiments combining both ...
www.aidsmap.org [cached]
Finally, in experiments combining both approaches, Luca Vangelista of the San Raffaele Scientific Institute in Italy has engineered the same lactobacilli as in the Xu study to produce human-type RANTES and is currently engineering another variant that will produce an analogue called C1C5-RANTES, and also small peptides - sections - derived from RANTES to see if these have anti-HIV activity.
Aidsmap | Microbicides 2008: Third-generation microbicides might act as ‘bacterial vaccine’
www.nam.org.uk [cached]
Finally, in experiments combining both approaches, Luca Vangelista of the San Raffaele Scientific Institute in Italy has engineered the same lactobacilli as in the Xu study to produce human-type RANTES and is currently engineering another variant that will produce an analogue called C1C5-RANTES, and also small peptides - sections - derived from RANTES to see if these have anti-HIV activity.
Other People with the name "Vangelista":
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304